Transgenic Mice with Mammary Gland Targeted Expression of Human Cortactin Do Not Develop (pre-malignant) Breast Tumors: Studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 Bitransgenic Mice

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2006 Mar 16

PMID 16536875

Citations 9

Authors

Agnes G S H van Rossum

Maaike P A van Bragt

Ellen Schuuring-Scholtes

Jan C M van der Ploeg

Johan H J M van Krieken

Philip M Kluin

Ed Schuuring

Affiliations

Soon will be listed here.

Abstract

Background: In human breast cancers, amplification of chromosome 11q13 correlates with lymph node metastasis and increased mortality. To date, two genes located within this amplicon, CCND1 and EMS1, were considered to act as oncogenes, because overexpression of both proteins, respectively cyclin D1 and cortactin, correlated well with 11q13 amplification. Cyclin D1 is involved in cell cycle regulation and the F-actin-binding protein cortactin in cytoskeletal dynamics and cell migration. To study the role of cortactin in mammary gland tumorigenesis, we examined mouse mammary tumor virus (MMTV)-cortactin transgenic mice and MMTV-cortactin/-MMTV-cyclin D1 bitransgenic mice.

Methods: MMTV-cortactin transgenic mice were generated and intercrossed with previously described MMTV-cyclin D1 transgenic mice. Immunohistochemical, Northern and Western blot analyses were performed to study the expression of human transgene cortactin during mammary gland development and in mammary tumors. For tumor incidence studies, forced-bred, multiparous mice were used to enhance transgene expression in the mammary gland. Microscopical examination was performed using haematoxylin and eosin staining.

Results: Mammary gland tumors arose stochastically (incidence 21%) with a mean age of onset at 100 weeks. This incidence, however, did not exceed that of aged-matched control FVB/N mice (38%), which unexpectedly, also developed spontaneous mammary gland tumors. We mimicked 11q13 amplification by generating MMTV-cortactin/-MMTV-cyclin D1 bitransgenic mice but did not observe any synergistic effect of cortactin on cyclin D1-induced mammary hyperplasias or carcinomas, nor development of distant metastasis.

Conclusion: From this study, we conclude that development of (pre-malignant) breast tumors in either wild type or MMTV-cyclin D1 mice was not augmented due to mammary gland targeted overexpression of human cortactin.

Citing Articles

Effects of Cortactin Expression on Prognosis in Patients with Breast Cancer.

Son H, Jee S, Cha H, Song K, Bang S, Kim H Diagnostics (Basel). 2023; 13(18).

PMID: 37761244 PMC: 10530131. DOI: 10.3390/diagnostics13182876.

Prognostic significance and immune correlates of FADD in penile squamous cell carcinoma.

Xue T, Yan R, Li Z, Guo S, Xiao X, Jin J Virchows Arch. 2023; 482(5):869-878.

PMID: 36813950 DOI: 10.1007/s00428-023-03514-9.

Advances in Rodent Models for Breast Cancer Formation, Progression, and Therapeutic Testing.

Liu C, Wu P, Zhang A, Mao X Front Oncol. 2021; 11:593337.

PMID: 33842308 PMC: 8032937. DOI: 10.3389/fonc.2021.593337.

Association of CTTN polymorphisms with the risk of colorectal cancer.

Lee S, Kang D, Park W, Lee J, Cheon Chae S J Korean Surg Soc. 2012; 82(3):156-64.

PMID: 22403749 PMC: 3294109. DOI: 10.4174/jkss.2012.82.3.156.

Cortactin: a multifunctional regulator of cellular invasiveness.

Kirkbride K, Sung B, Sinha S, Weaver A Cell Adh Migr. 2011; 5(2):187-98.

PMID: 21258212 PMC: 3084985. DOI: 10.4161/cam.5.2.14773.

References

Nieto A, Shyamala G, Galvez J, Thordarson G, Wakefield L, Cardiff R . Persistent mammary hyperplasia in FVB/N mice. Comp Med. 2003; 53(4):433-8. View

Siesling S, Van Dijck J, Visser O, Coebergh J . Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer. 2003; 39(17):2521-30. DOI: 10.1016/s0959-8049(03)00622-1. View

van Rossum A, de Graaf J, Schuuring-Scholtes E, Kluin P, Fan Y, Zhan X . Alternative splicing of the actin binding domain of human cortactin affects cell migration. J Biol Chem. 2003; 278(46):45672-9. DOI: 10.1074/jbc.M306688200. View

Helwani F, Kovacs E, Paterson A, Verma S, Ali R, Fanning A . Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol. 2004; 164(6):899-910. PMC: 2172285. DOI: 10.1083/jcb.200309034. View

Daly R . Cortactin signalling and dynamic actin networks. Biochem J. 2004; 382(Pt 1):13-25. PMC: 1133910. DOI: 10.1042/BJ20040737. View

Cardiff R, Anver M, Gusterson B, Hennighausen L, Jensen R, Merino M . The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene. 2000; 19(8):968-88. DOI: 10.1038/sj.onc.1203277. View

Compagni A, Christofori G . Recent advances in research on multistage tumorigenesis. Br J Cancer. 2000; 83(1):1-5. PMC: 2374546. DOI: 10.1054/bjoc.2000.1309. View

Weed S, Karginov A, Schafer D, Weaver A, Kinley A, Cooper J . Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol. 2000; 151(1):29-40. PMC: 2189811. DOI: 10.1083/jcb.151.1.29. View

Uruno T, Liu J, Zhang P, Fan Yx , Egile C, Li R . Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol. 2001; 3(3):259-66. DOI: 10.1038/35060051. View

10.

Yu Q, Geng Y, Sicinski P . Specific protection against breast cancers by cyclin D1 ablation. Nature. 2001; 411(6841):1017-21. DOI: 10.1038/35082500. View

11.

Li Y, Tondravi M, Liu J, Smith E, Haudenschild C, Kaczmarek M . Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 2001; 61(18):6906-11. View

12.

Hosokawa Y, Papanikolaou A, Cardiff R, Yoshimoto K, Bernstein M, Wang T . In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. Transgenic Res. 2001; 10(5):471-8. DOI: 10.1023/a:1012064911751. View

13.

Wakefield L, Thordarson G, Nieto A, Shyamala G, Galvez J, Anver M . Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med. 2003; 53(4):424-32. View

14.

El Sayegh T, Arora P, Laschinger C, Lee W, Morrison C, Overall C . Cortactin associates with N-cadherin adhesions and mediates intercellular adhesion strengthening in fibroblasts. J Cell Sci. 2004; 117(Pt 21):5117-31. DOI: 10.1242/jcs.01385. View

15.

Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P . Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987; 49(4):465-75. DOI: 10.1016/0092-8674(87)90449-1. View

16.

Krimpenfort P, Berns A . Gene transfer into mammalian embryos. Hum Reprod. 1987; 2(4):333-9. DOI: 10.1093/oxfordjournals.humrep.a136545. View

17.

Muller W, Sinn E, Pattengale P, Wallace R, Leder P . Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 1988; 54(1):105-15. DOI: 10.1016/0092-8674(88)90184-5. View

18.

Bouchard L, LAMARRE L, Tremblay P, Jolicoeur P . Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell. 1989; 57(6):931-6. DOI: 10.1016/0092-8674(89)90331-0. View

19.

Morgenstern J, Land H . A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 1990; 18(4):1068. PMC: 330385. DOI: 10.1093/nar/18.4.1068. View

20.

Bishop J . Molecular themes in oncogenesis. Cell. 1991; 64(2):235-48. DOI: 10.1016/0092-8674(91)90636-d. View